DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Kasahara N, Fukase H, Ohba Y. et al.
A pharmacokinetic/pharmacodynamic drug-drug interaction study of tofogliflozin (a new SGLT2 inhibitor) and selected anti-type 2 diabetes mellitus drugs.
Drug Res (Stuttg) 2016;
66: 74-81
We do not assume any responsibility for the contents of the web pages of other providers.